Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Piromac 20mg Tablet DT

Prescription Icon
Prescription Required

Marketer

Blubell Pharma

Salt Composition

Piroxicam (20mg)

Overview Piromac 20mg Tablet DT

Arthrimax 20mg Delayed-Release Tablets provide relief from moderate to severe pain. Indicated for osteoarthritis and rheumatoid arthritis, it alleviates joint and muscle pain and inflammation. Always take Arthrimax 20mg tablets with food to minimize stomach upset. Dosage and treatment length vary depending on individual response and condition. Continue taking the medication as prescribed, even after symptom improvement, until your physician advises discontinuation. Common side effects include nausea, mild vomiting, headache, dizziness, and abdominal discomfort. Report persistent or worsening side effects to your doctor, who can offer management strategies. Prior to use, inform your doctor of any pre-existing conditions, such as ulcers, cardiovascular disease, hypertension, liver or kidney impairment. Also disclose all other medications you are currently using, as interactions may occur. Consult your doctor before using Arthrimax 20mg tablets if you are pregnant or breastfeeding.

Uses of Piromac 20mg Tablet DT

Analgesia

Major Benefits of Piromac 20mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Piromac 20mg Tablet DT in water before consumption. It should be administered with food.

Common Side effects of Piromac 20mg Tablet DT:

  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Piromac 20mg Tablet DT:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Piromac 20mg Tablet DT in water before consumption. It should be administered with a meal.

How Piromac 20mg Tablet DT works:

Piromac 20mg Delayed-Release Tablets contain a non-steroidal anti-inflammatory agent that inhibits the production of inflammatory mediators, thereby reducing pain and swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Piromac 20mg Tablet DT and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Piromac 20mg Delayed-Release Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Piromac 20mg Tablet DT while breastfeeding is likely inadvisable. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking Piromac 20mg DT tablets, as these side effects may impair alertness.

KidneyKidneyCAUTION

Patients with significant kidney impairment should exercise caution when using Piromac 20mg Tablet DT. Dosage modification of Piromac 20mg Tablet DT might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Piromac 20mg Delayed-Release Tablets cautiously. Dosage modification of Piromac 20mg Delayed-Release Tablets may be necessary. Physician consultation is recommended.

What if you forget to take Piromac 20mg Tablet DT :

Should you forget to take your Piromac 20mg Tablet DT, ingest the dose at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Piromac 20mg Tablet DT

LabelValue
Type of Compound Compounds derived from enolic acids
Addictive None.
Type of Treatment Medications for pain relief

FAQs on Piromac 20mg Tablet DT

Piroxicam (Piromac 20mg Tablet DT) and diclofenac are analgesics. Piroxicam, though, is a non-selective cyclooxygenase (COX) inhibitor, while diclofenac exhibits greater COX-2 enzyme selectivity. This enhanced selectivity in diclofenac is believed to reduce the incidence of adverse effects relative to piroxicam.
Piromac 20mg Tablet DT and naproxen are analgesics, both non-selectively inhibiting COX enzymes, which mediate pain and inflammation. Clinical trials demonstrate comparable efficacy for both drugs. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse effects than Piromac 20mg Tablet DT.
Piromac 20mg Tablet DT and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain perception. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse events than Piromac 20mg Tablet DT.
Piromac 20mg Tablet DT and ketoprofen are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate superior efficacy of topical ketoprofen gel over Piromac 20mg Tablet DT. Furthermore, ketoprofen gel demonstrated excellent patient acceptance.
Piromac 20mg Delayed-Release Tablets target COX enzymes, which contribute to inflammation and pain. In contrast, Tramadol functions as an opioid analgesic. Tramadol carries a risk of dependence.
Piroxicam (as in Piromac 20mg Tablet DT) and nimesulide are analgesics. Piroxicam, however, is a non-selective cyclooxygenase (COX) inhibitor, while nimesulide selectively targets COX-2. This selectivity in nimesulide is believed to reduce adverse reactions relative to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet count. However, analgesics such as piroxicam increase the risk of bleeding. Therefore, avoid taking Piromac 20mg Tablet DT or other pain relievers if you experience fever with joint pain. Seek medical advice before using Piromac 20mg Tablet DT.
Piromac 20mg Tablet DT and aspirin are distinct medications, although both are classified as COX (cyclooxygenase) inhibitors, sharing anti-inflammatory and analgesic properties.
Concurrent administration of Piromac 20mg Tablet DT and dexamethasone is contraindicated due to the potential for synergistic toxicity, notably an elevated risk of gastrointestinal ulceration.
Concurrent use of methocarbamol and Piromac 20mg Tablet DT is considered safe, lacking documented significant adverse interactions. However, physician consultation is advised prior to initiating either treatment.
Paracetamol's concurrent use with Piromac 20mg DT tablets is considered safe, lacking documented significant adverse interactions. However, physician consultation is recommended prior to initiating either treatment.
Affirmative. Piromac 20mg Delayed-Release Tablets are classified as a non-steroidal anti-inflammatory drug.
The medication Piromac 20mg Tablet DT, a sulfur-based formulation, may induce serious side effects in susceptible patients. Severe cutaneous reactions, including Stevens-Johnson syndrome, are possible. Allergic individuals should disclose their allergy history to their physician.
Piromac 20mg Tablet DT is an analgesic, not an anticoagulant. Its use is contraindicated in individuals with hemorrhagic conditions.
Piromac 20mg Delayed-Release Tablets do not relax muscles. This analgesic targets the COX enzyme (cyclooxygenase), an enzyme involved in pain and inflammation.
Piromac 20mg Tablet DT is a non-narcotic analgesic. Its mechanism of action involves inhibiting cyclooxygenase (COX), an enzyme crucial in inflammatory and pain processes, thereby reducing both pain and inflammation.
Piromac 20mg Tablet DT does not treat high blood pressure. Concurrent use with antihypertensive drugs reduces their efficacy. Disclose any antihypertensive medication use to your physician prior to commencing Piromac 20mg Tablet DT.
Concurrent use of Piromac 20mg Tablet DT and Losartan is contraindicated. Piromac 20mg Tablet DT diminishes the efficacy of antihypertensive agents such as Losartan, potentially resulting in ineffective blood pressure control. Disclose any current antihypertensive medication use to your physician prior to commencing Piromac 20mg Tablet DT treatment.
Concurrent use of Piromac 20mg Tablet DT and lisinopril is contraindicated. Piroxicam diminishes the antihypertensive effect of medications such as lisinopril, potentially resulting in inadequate blood pressure control. Disclose any antihypertensive medication use to your physician prior to commencing Piromac 20mg Tablet DT treatment.
Affirmative. Concurrent use of Piromac 20mg Delayed-Release Tablets and calcium channel blockers is permissible. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) may lessen the efficacy of most antihypertensive medications, with calcium channel blockers representing an exception (White, 2007).
Tizanidine can be safely used concurrently with Piromac 20mg Delayed-Release Tablets. Piroxicam, an analgesic, and the skeletal muscle relaxant tizanidine are often combined for conditions such as back pain.
Affirmative. Concomitant administration of Piromac 20mg Tablet DT and beta-cyclodextrin is feasible. Studies indicate this combination accelerates piroxicam's therapeutic effect and mitigates gastrointestinal adverse reactions.
Indeed, viable alternatives to Piroxicam 20mg extended-release tablets exist. Analgesic selection depends on the specific ailment. Physician consultation is advisable before initiating piroxicam therapy or switching medications.
Piroxicam should be avoided in patients with allergies, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores (stomatitis), systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-term pregnancy, heart conditions, liver dysfunction, or kidney impairment.
Piromac 20mg Tablet DT does not treat allergies; it is an analgesic.
Piroxicam 20mg extended-release tablets provide prolonged pain relief. A single daily dose often suffices, though individual responses vary; the analgesic effect of piroxicam typically enhances with continued use over several weeks.
Piromac 20mg Tablet DT is not associated with elevated blood pressure. This medication is a non-opioid analgesic.
The medication Piromac 20mg Tablet DT lacks regulatory approval for managing dysmenorrhea. However, investigations indicate piroxicam demonstrably reduces the severity of menstrual cramps.
The medication Piromac 20mg Tablet DT lacks regulatory approval for migraine treatment. Clinical trials, however, indicate its efficacy in substantially reducing migraine pain in individuals without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's evaluation to determine the underlying cause of your back pain is crucial before commencing treatment. Avoid self-treating with Piromac 20mg Tablet DT, as the etiology of back pain varies individually.
Acute gout may be treated with Piromac 20mg Tablet DT. Clinical trials indicate Piromac 20mg Tablet DT demonstrates significant efficacy in managing acute gout episodes.
Blood donation is permissible while taking Piromac 20mg Tablet DT; however, it's crucial to disclose this medication use to your physician prior to donation.
In patients with diabetes, the use of Piromac 20mg Tablet DT requires strict medical supervision. Prolonged use of this medication carries a significant risk of renal impairment. Since diabetes is an independent risk factor for kidney disease, adding piroxicam considerably elevates the likelihood of renal failure.
Individuals with impaired kidney function should avoid Piromac 20mg Delayed-Release Tablets. Prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with kidney damage, including papillary necrosis.
Affirmative. Piromac 20mg Delayed-Release Tablets have been associated with potentially serious cutaneous adverse reactions, including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). These reactions can be life-threatening and may develop unexpectedly. Report any skin rash, even if mild, to your physician and cease medication immediately.
The use of Piromac 20mg Delayed-Release Tablets is contraindicated during pregnancy. This medication can induce premature closure of the ductus arteriosus, potentially resulting in fetal cardiac failure and infant mortality.
Piromac 20mg Tablet DT is not suitable for patients with active peptic ulcers. This medication has been associated with the development of gastric ulcers and bleeding.
Individuals with asthma may experience heightened sensitivity to non-steroidal anti-inflammatory medications, such as aspirin, potentially triggering severe asthma episodes. Physician consultation is advised prior to commencing treatment with these drugs.
Affirmative. The drug Piromac 20mg Tablet DT may induce temporary infertility in some patients. Piroxicam's mode of action potentially inhibits or postpones the release of ovarian follicles, a factor linked to reversible infertility. Physician consultation is advised prior to commencing treatment.
Piromac 20mg Tablet DT is contraindicated for concurrent use with diuretics. In certain individuals, Piromac 20mg Tablet DT diminishes the sodium-excreting action of furosemide and thiazide diuretics. This effect is believed to result from the suppression of renal prostaglandin production.
Lithium and Piromac 20mg Tablet DT are contraindicated. Piromac 20mg Tablet DT increases plasma lithium concentrations and decreases lithium's renal clearance due to its nonsteroidal anti-inflammatory drug (NSAID) properties, which inhibit renal prostaglandin production. Physician consultation is mandatory prior to commencing this treatment.
Concomitant use of Piromac 20mg Tablet DT and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose all medications to their physician. If co-administration is unavoidable, close monitoring of the treatment regimen is essential.
Individuals using corticosteroids and anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional risk factors for ulcer formation.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin or any nonsteroidal anti-inflammatory drug (NSAID), or those who had such a reaction immediately preceding or following coronary artery bypass grafting.
Gastrointestinal upset, and infrequently, severe gastrointestinal adverse reactions including ulcers and hemorrhage; serious dermatological reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; hepatic failure; and kidney injury.
Piromac 20mg Tablet DT
27
MRP 33
18% off